Status:
TERMINATED
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
Lead Sponsor:
Pfizer
Conditions:
Cardiovascular Disease
Cerebrovascular Disorders
Eligibility:
All Genders
10+ years
Brief Summary
An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin P...
Detailed Description
Study A5091075, an observational study in subjects who had previously been treated with torcetrapib, was terminated on 20 Dec 2007. The study was terminated following reviews of final safety informati...
Eligibility Criteria
Inclusion
- Have signed informed consent prior to the initiation of any study-specific activities.
- Have participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials and were treated with randomized study medication.
Exclusion
- There are no exclusion criteria.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
26784 Patients enrolled
Trial Details
Trial ID
NCT00452842
Start Date
October 1 2007
Last Update
February 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Clearwater, Florida, United States, 33756